Your browser doesn't support javascript.
loading
Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients.
Huang, Yiqing; Soon, Yu Yang; Aminkeng, Folefac; Tay, Sen Hee; Ang, Yvonne; Kee, Adrian C L; Goh, Boon Cher; Wong, Alvin S C; Soo, Ross A.
Affiliation
  • Huang Y; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Soon YY; Department of Radiation Oncology, National University Cancer Institute, Singapore, Singapore.
  • Aminkeng F; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Tay SH; Department of Medicine, Rheumatology Division, National University Hospital, Singapore.
  • Ang Y; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Kee ACL; Department of Medicine, Respiratory Division, National University Hospital, Singapore.
  • Goh BC; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Wong ASC; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Soo RA; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
Int J Cancer ; 150(4): 636-644, 2022 02 15.
Article in En | MEDLINE | ID: mdl-34562273
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Immune Checkpoint Inhibitors / Lung Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Immune Checkpoint Inhibitors / Lung Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2022 Document type: Article Affiliation country: Country of publication: